Microplate Dx leads in rapid diagnostics to combat antimicrobial resistance, ensuring accurate antibiotic treatments from the outset. Safeguarding against the spread of antimicrobial resistance worldwide About Us Microplate DX is on the forefront of combating antimicrobial resistance globally, ensuring patients receive the correct antibiotic treatment from the start. Our rapid, cost-effective point of care solution improves antibiotic stewardship by eliminating guesswork in prescribing, focusing initially on urinary tract infections—a leading cause of antibiotic treatment. Explore Our Innovation Our first product targets UTIs to prevent unnecessary antibiotic use and fight antimicrobial resistance. The AI-driven platform is versatile, suited for a broad range of organisms and antibiotic combinations, showcasing our commitment to tomorrow's diagnostics today. Get in Touch Website LinkedIn Twitter This article was published on 2024-06-06
